New report published by Global Info Research which offers insights on the global Bacillus Coagulans market.
Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey’s Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
Click to view the full report TOC, figure and tables:
Global Bacillus Coagulans Market: Forecast by Type / Application / Region
Bacillus Coagulans in Global market focuses on the top Manufacturers in each country, covering: Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, Syngen Biotech, Sanzyme, Microbax.
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into: Below 100 B, 100-200 B, Above 200 B.
Split by applications be divided into: Drugs, Food, Beverage, Supplement Products.
In the last several years, Global market of Bacillus Coagulans developed rapidly, with an average growth rate of 9%. In 2016, Global Revenue of Bacillus Coagulans is nearly 16.8 M USD; the actual sales are about 26 MT.
The global average price of Bacillus Coagulans is in the increasing trend, from 620 USD/Kg in 2012 to 650 USD/Kg in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Bacillus Coagulans includes Below 100 B, 100-200 B and Above 200 B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2016 is about 47%.
Bacillus Coagulans is widely used in Drugs, Food, Beverage and Supplement Products. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2016 is 37.5%. The trend of Supplement Products is increasing.
North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Bacillus Coagulans Market 2018 Forecast to 2023
Europe Bacillus Coagulans Market 2018 Forecast to 2023
North America Bacillus Coagulans Market 2018 Forecast to 2023
Asia-Pacific Bacillus Coagulans Market 2018 Forecast to 2023
China Bacillus Coagulans Market 2018 Forecast to 2023
EMEA Bacillus Coagulans Market 2018 Forecast to 2023
Global Bacillus Coagulans Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-15521064060 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong